Insight

Life Sciences Business Evolution Series

Explore how pharma biotech, medical devices and medtech companies plan to evolve their business models, shaping the future of the life sciences ecosystem.
Read More

We specialize in advising on digital health products and initiatives on a local, regional and global scale.

Our team of lawyers spans across geographies and specialisms, including healthcare regulation, technology, public procurement, intellectual property, compliance and investigations, data privacy and M&A. Our global network of lawyers includes 800+ life sciences lawyers, 150+ data privacy lawyers and 450+ IP and technology lawyers. We leverage this network to bring you holistic, practical advice on complex issues at the intersection of healthcare, data and tech.

We have a rich track record of partnering with organizations across the digital health ecosystem, including medtechs, pharmaceuticals, startups, biotechs, data science companies, and venture capital and private equity firms. For more information, please reach out to the key contacts listed on this page. 

  • Real-world data/evidence: Advising clients on all aspects of patient registries, from accessing datasets to commercialization of registries. We specialize in medical dataset licensing, including from government bodies, and academic and medical institutions.
  • Telehealth: Supporting clients on rolling out telehealth solutions on a local, regional and global scale, including doctor-on-demand apps, remotely controlled medical devices and cross-border provision of telemedicine services (including provision to hospitals, clinical trial participants and directly to patients).
  • Innovation in clinical trials: Advising CROs, tech providers and sponsors on all aspects of implementing of decentralized clinical trials across the globe, including in Europe, Asia Pacific and the Americas. Advising on acquiring and implementing technology solutions in clinical trials, from patient recruitment software to clinical trial management tools.
  • Medical devices, apps and wearables: Developing strategies with clients to bring innovative products to market, including device classification and implementing "guard rails" to ensure a product is not regulated as a device. Advising on clinical evaluation, regulatory approvals, advertising and promotion rules, and pricing and reimbursement.
  • AI and machine learning: Supporting some of the pioneers in AI on the full life cycle of AI as a medical device, from initially licensing in datasets to train an algorithm, to supply to hospitals. We have worked side by side with innovators to bring AI and machine learning products from the ideation stage to market.
  • Patient data: Advising clients on building and maintaining regional and global data privacy compliance programs centered on the regulation of health data. Advising on all aspects of health data regulation, from data privacy laws to local laws on medical confidentiality and the healthcare regulatory framework.

UK MHRA Launches Guidelines on Real World Data: 5 Takeaways
January 4, 2022, Viewpoints
Author: Jaspreet Takhar

Software and AI as a Medical Device: 10 Clues from the MHRA on the New UK Regime
September 30, 2021, Viewpoints
Author: Jaspreet Takhar

The Real Issue with Health Data Regulation: An Open Letter to UK Policymakers
April 20, 2021, Viewpoints
Author: Jaspreet Takhar

Abu Dhabi Department of Health Zeroes in on Information Security compliance
November 9, 2020, Viewpoints
Author: Kellie Blyth

The UK's NHSX Launches an Information Governance Portal
October 15, 2020, Viewpoints
Author: Jaspreet Takhar

Top 5 Takeaways from New MHRA Guidance on Medical Device Software
July 10, 2020, Viewpoints
Author: Jaspreet Takhar